Abstract
Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.
Original language | English (US) |
---|---|
Article number | e017013 |
Journal | Journal of the American Heart Association |
Volume | 9 |
Issue number | 12 |
DOIs | |
State | Published - Jun 16 2020 |
Funding
Disclosures provided by Dr London in compliance with American Heart Association’s annual Journal Editor Disclosure Questionnaire are available at https://www.ahajournals.org/pb-assets/COI_09-2019.pdf. Dr Addison is supported by a National Cancer Institute K12CA133250 grant, Dr Grumbach by funding from the National Institutes of Health (R01 HL 108932), the Department of Veterans Affairs (I21 RX001561), and the American Heart Association (18IPA34170003). The remaining authors have no conflicts to disclose.
Keywords
- COVID-19
- Cardiovascular disease
- Cardiovascular risk factors
- Coronavirus disease 2019
- Management
- SARS-CoV-2
- Treatment
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine